Research Article

Significance of Methylation of FBP1 Gene in Non-Small Cell Lung Cancer

Table 1

Association of FBP1 DNA methylation level with clinicopathological factors in the cancer tissue of patients with NSCLC.

FactorsPatients, n(%)FBP1PFBP1P
Median (Mean, 5th-95th)Low methylation n( % )High methylation n( % )

Sex0.0260.009
Male90(84.11)4.86(7.86,5.76-10.00)58(54.21)52(48.60)
Female17(15.89)3.75(4.40,1.76-7.03)13(12.15)4(3.74)
Age(years)0.3410.464
6577(71.96)4.50(6.70,5.07-8.32)35(32.71)42(39.25)
6530(28.04)4.13(8.91,3.74-14.10)16(14.95)14(13.09)
Family History0.7520.817
no87(81.31)4.50(6.51,4.93-8.09)41(38.31)46(42.99)
yes20(18.69)4.38(10.81,3.57-18.06)10(9.35)10(9.35)
Smoking0.0030.008
Never22(20.56)3.50(3.83,1.97-5.69)16(14.95)6(5.61)
Ever/Current85(79.44)5.25(8.22,6.00-10.43)35(32.71)50(46.73)
Alcohol0.2900.164
Never45(42.06)4.25(6.52,3.71-9.34)25(23.36)20(18.69)
Ever/Current62(57.94)5.13(7.89,5.44-10.33)26(24.31)36(33.64)
Histologic type0.1600.579
Squamous cell carcinoma37(34.58)4.25(5.01,3.09-6.93)19(17.76)18(16.82)
Adenocarcinoma70(65.42)5.00(8.53,5.95-11.11)32(29.91)38(35.51)
Grade0.0730.004
high-middle58(54.21)4.00(7.47,4.53-10.42)35(32.71)23(21.50)
middle-low49(45.79)5.50(7.12,5.09-9.15)1614.95()33(30.84)
Clinical stage0.9520.760
I - II83(77.57)4.50(7.23,5.22-9.24)36(33.64)38(35.51)
III24 (22.43)4.38(7.60,3.10-12.11)15(14.02)18(16.82)